参考文献
本文中で引用した文献の一覧です。
ノート出典の確認方法
- 英語の論文はすべて PubMed で書誌情報(著者・雑誌・巻・号・ページ・DOI・PMID)を照合 し、本文で使った主張・数値は 各論文の抄録 (abstract) で確認 しました。抄録のない文献(総説・コンセンサス声明など)は、タイトルと書誌情報の範囲で、論点を確認できるものに限って引用しています。
- 教科書 (Pawlina と Ross 2020年) は、組織像の一般的な記載の出典として挙げています。
- 本文の細部まで確認できていない文献もあります。講義や論文で引用する場合は、必ず原典(DOI のリンク先)を確認してください。
Arita, Y., S. Kihara, N. Ouchi, et al. 1999. “Paradoxical decrease of an adipose-specific protein,
adiponectin, in obesity.” Biochemical and Biophysical
Research Communications 257 (1): 79–83. https://doi.org/10.1006/bbrc.1999.0255.
Arner, E., P. O. Westermark, K. L. Spalding, et al. 2010. “Adipocyte turnover: relevance to human adipose tissue
morphology.” Diabetes 59 (1): 105–9. https://doi.org/10.2337/db09-0942.
Arner, P. 2005. “Human fat cell lipolysis:
biochemistry, regulation and clinical role.” Best
Practice & Research. Clinical Endocrinology & Metabolism 19
(4): 471–82. https://doi.org/10.1016/j.beem.2005.07.004.
Björntorp, P. 1990. “"Portal"
adipose tissue as a generator of risk factors for cardiovascular disease
and diabetes.” Arteriosclerosis (Dallas,
Tex.) 10 (4): 493–96.
Bujalska, I. J., S. Kumar, and P. M. Stewart. 1997. “Does central obesity reflect "Cushing’s disease of the
omentum"?” Lancet (London, England) 349 (9060):
1210–13. https://doi.org/10.1016/S0140-6736(96)11222-8.
Cancello, R., J. Tordjman, C. Poitou, et al. 2006. “Increased infiltration of macrophages in omental adipose
tissue is associated with marked hepatic lesions in morbid human
obesity.” Diabetes 55 (6): 1554–61. https://doi.org/10.2337/db06-0133.
Chaston, T. B., and J. B. Dixon. 2008. “Factors associated with percent change in visceral versus
subcutaneous abdominal fat during weight loss: findings from a
systematic review.” International Journal of Obesity
(2005) 32 (4): 619–28. https://doi.org/10.1038/sj.ijo.0803761.
Chau, Y. Y., R. Bandiera, A. Serrels, et al. 2014. “Visceral and subcutaneous fat have different origins and
evidence supports a mesothelial source.” Nature Cell
Biology 16 (4): 367–75. https://doi.org/10.1038/ncb2922.
Cinti, S. 2005. “The adipose
organ.” Prostaglandins, Leukotrienes, and Essential
Fatty Acids 73 (1): 9–15. https://doi.org/10.1016/j.plefa.2005.04.010.
Cinti, S., G. Mitchell, G. Barbatelli, et al. 2005. “Adipocyte death defines macrophage localization and
function in adipose tissue of obese mice and humans.”
Journal of Lipid Research 46 (11): 2347–55. https://doi.org/10.1194/jlr.M500294-JLR200.
Cypess, A. M., S. Lehman, G. Williams, et al. 2009. “Identification and importance of brown adipose tissue in
adult humans.” The New England Journal of
Medicine 360 (15): 1509–17. https://doi.org/10.1056/NEJMoa0810780.
Eriksson-Hogling, D., D. P. Andersson, J. Bäckdahl, et al. 2015.
“Adipose tissue morphology predicts improved
insulin sensitivity following moderate or pronounced weight
loss.” International Journal of Obesity (2005) 39
(6): 893–98. https://doi.org/10.1038/ijo.2015.18.
Examination Committee of Criteria for ’Obesity Disease’ in Japan, and
Japan Society for the Study of Obesity. 2002. “New criteria for ’obesity disease’ in
Japan.” Circulation Journal : Official Journal of the
Japanese Circulation Society 66 (11): 987–92. https://doi.org/10.1253/circj.66.987.
Fried, S. K., D. A. Bunkin, and A. S. Greenberg. 1998. “Omental and subcutaneous adipose tissues of obese
subjects release interleukin-6: depot difference and regulation by
glucocorticoid.” The Journal of Clinical Endocrinology
and Metabolism 83 (3): 847–50. https://doi.org/10.1210/jcem.83.3.4660.
Friedman, J. M., and J. L. Halaas. 1998. “Leptin and the regulation of body weight in
mammals.” Nature 395 (6704): 763–70. https://doi.org/10.1038/27376.
Garg, A. 2004. “Acquired and inherited
lipodystrophies.” The New England Journal of
Medicine 350 (12): 1220–34. https://doi.org/10.1056/NEJMra025261.
Gesta, S., M. Blüher, Y. Yamamoto, et al. 2006. “Evidence for a role of developmental genes in the origin
of obesity and body fat distribution.” Proceedings of
the National Academy of Sciences of the United States of America
103 (17): 6676–81. https://doi.org/10.1073/pnas.0601752103.
Hall, K. D. 2008. “What is the required
energy deficit per unit weight loss?” International
Journal of Obesity (2005) 32 (3): 573–76. https://doi.org/10.1038/sj.ijo.0803720.
Hoffstedt, J., E. Arner, H. Wahrenberg, et al. 2010. “Regional impact of adipose tissue morphology on the
metabolic profile in morbid obesity.”
Diabetologia 53 (12): 2496–503. https://doi.org/10.1007/s00125-010-1889-3.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993.
“Adipose expression of tumor necrosis
factor-alpha: direct role in obesity-linked insulin
resistance.” Science (New York, N.Y.) 259 (5091):
87–91. https://doi.org/10.1126/science.7678183.
Ibrahim, M. M. 2010. “Subcutaneous and
visceral adipose tissue: structural and functional
differences.” Obesity Reviews : An Official Journal of
the International Association for the Study of Obesity 11 (1):
11–18. https://doi.org/10.1111/j.1467-789X.2009.00623.x.
Kelley, D. E., F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster.
2000. “Subdivisions of subcutaneous abdominal
adipose tissue and insulin resistance.” American
Journal of Physiology. Endocrinology and Metabolism 278 (5):
E941–8. https://doi.org/10.1152/ajpendo.2000.278.5.E941.
Knittle, J. L., K. Timmers, F. Ginsberg-Fellner, R. E. Brown, and D. P.
Katz. 1979. “The growth of adipose tissue in
children and adolescents. Cross-sectional and longitudinal studies of
adipose cell number and size.” The Journal of Clinical
Investigation 63 (2): 239–46. https://doi.org/10.1172/JCI109295.
Kuk, J. L., T. J. Saunders, L. E. Davidson, and R. Ross. 2009.
“Age-related changes in total and regional
fat distribution.” Ageing Research Reviews 8 (4):
339–48. https://doi.org/10.1016/j.arr.2009.06.001.
Lee, M. J., Y. Wu, and S. K. Fried. 2013. “Adipose tissue heterogeneity: implication of depot
differences in adipose tissue for obesity complications.”
Molecular Aspects of Medicine 34 (1): 1–11. https://doi.org/10.1016/j.mam.2012.10.001.
Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M.
Willson, and S. A. Kliewer. 1995. “An
antidiabetic thiazolidinedione is a high affinity ligand for peroxisome
proliferator-activated receptor gamma (PPAR gamma).”
The Journal of Biological Chemistry 270 (22): 12953–56. https://doi.org/10.1074/jbc.270.22.12953.
Loke, Y. K., S. Singh, and C. D. Furberg. 2009. “Long-term use of thiazolidinediones and fractures in type
2 diabetes: a meta-analysis.” CMAJ : Canadian Medical
Association Journal = Journal de l’Association Medicale Canadienne
180 (1): 32–39. https://doi.org/10.1503/cmaj.080486.
Lovejoy, J. C., C. M. Champagne, L. de Jonge, H. Xie, and S. R. Smith.
2008. “Increased visceral fat and decreased
energy expenditure during the menopausal transition.”
International Journal of Obesity (2005) 32 (6): 949–58. https://doi.org/10.1038/ijo.2008.25.
Maeda, K., K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K.
Matsubara. 1996. “cDNA cloning and expression
of a novel adipose specific collagen-like factor, apM1 (AdiPose Most
abundant Gene transcript 1).” Biochemical and
Biophysical Research Communications 221 (2): 286–89. https://doi.org/10.1006/bbrc.1996.0587.
Manolopoulos, K. N., F. Karpe, and K. N. Frayn. 2010. “Gluteofemoral body fat as a determinant of metabolic
health.” International Journal of Obesity (2005)
34 (6): 949–59. https://doi.org/10.1038/ijo.2009.286.
Mehlem, A., C. E. Hagberg, L. Muhl, U. Eriksson, and A. Falkevall. 2013.
“Imaging of neutral lipids by oil red O for
analyzing the metabolic status in health and disease.”
Nature Protocols 8 (6): 1149–54. https://doi.org/10.1038/nprot.2013.055.
Meza-Perez, S., and T. D. Randall. 2017. “Immunological Functions of the Omentum.”
Trends in Immunology 38 (7): 526–36. https://doi.org/10.1016/j.it.2017.03.002.
Miyazaki, Y., A. Mahankali, M. Matsuda, et al. 2002. “Effect of pioglitazone on abdominal fat distribution and
insulin sensitivity in type 2 diabetic patients.” The
Journal of Clinical Endocrinology and Metabolism 87 (6): 2784–91.
https://doi.org/10.1210/jcem.87.6.8567.
Nesto, R. W., D. Bell, R. O. Bonow, et al. 2003. “Thiazolidinedione use, fluid retention, and congestive
heart failure: a consensus statement from the American Heart Association
and American Diabetes Association. October 7, 2003.”
Circulation 108 (23): 2941–48. https://doi.org/10.1161/01.CIR.0000103683.99399.7E.
Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen.
2004. “Splanchnic lipolysis in human
obesity.” The Journal of Clinical Investigation
113 (11): 1582–88. https://doi.org/10.1172/JCI21047.
Oral, E. A., V. Simha, E. Ruiz, et al. 2002. “Leptin-replacement therapy for
lipodystrophy.” The New England Journal of
Medicine 346 (8): 570–78. https://doi.org/10.1056/NEJMoa012437.
Ouchi, N., S. Kihara, Y. Arita, et al. 1999. “Novel modulator for endothelial adhesion molecules:
adipocyte-derived plasma protein adiponectin.”
Circulation 100 (25): 2473–76. https://doi.org/10.1161/01.cir.100.25.2473.
Pawlina, W., and M. H. Ross. 2020. Histology: A
Text and Atlas: With Correlated Cell and Molecular Biology.
8th ed. Wolters Kluwer.
Rosen, E. D., and B. M. Spiegelman. 2014. “What we talk about when we talk about fat.”
Cell 156 (1-2): 20–44. https://doi.org/10.1016/j.cell.2013.12.012.
Ryo, M., T. Nakamura, S. Kihara, et al. 2004. “Adiponectin as a biomarker of the metabolic
syndrome.” Circulation Journal : Official Journal of
the Japanese Circulation Society 68 (11): 975–81. https://doi.org/10.1253/circj.68.975.
Scherer, P. E., S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish.
1995. “A novel serum protein similar to C1q,
produced exclusively in adipocytes.” The Journal of
Biological Chemistry 270 (45): 26746–49. https://doi.org/10.1074/jbc.270.45.26746.
Shimomura, I., T. Funahashi, M. Takahashi, et al. 1996. “Enhanced expression of PAI-1 in visceral fat: possible
contributor to vascular disease in obesity.” Nature
Medicine 2 (7): 800–803. https://doi.org/10.1038/nm0796-800.
Spalding, K. L., E. Arner, P. O. Westermark, et al. 2008. “Dynamics of fat cell turnover in humans.”
Nature 453 (7196): 783–87. https://doi.org/10.1038/nature06902.
Stenkula, K. G., and C. Erlanson-Albertsson. 2018. “Adipose cell size: importance in health and
disease.” American Journal of Physiology. Regulatory,
Integrative and Comparative Physiology 315 (2): R284–95. https://doi.org/10.1152/ajpregu.00257.2017.
Sun, K., C. M. Kusminski, and P. E. Scherer. 2011. “Adipose tissue remodeling and obesity.”
The Journal of Clinical Investigation 121 (6): 2094–101. https://doi.org/10.1172/JCI45887.
Tchkonia, T., D. E. Morbeck, T. Von Zglinicki, et al. 2010. “Fat tissue, aging, and cellular
senescence.” Aging Cell 9 (5): 667–84. https://doi.org/10.1111/j.1474-9726.2010.00608.x.
Tchkonia, T., Y. D. Tchoukalova, N. Giorgadze, et al. 2005. “Abundance of two human preadipocyte subtypes with
distinct capacities for replication, adipogenesis, and apoptosis varies
among fat depots.” American Journal of Physiology.
Endocrinology and Metabolism 288 (1): E267–77. https://doi.org/10.1152/ajpendo.00265.2004.
Tchkonia, T., T. Thomou, Y. Zhu, et al. 2013. “Mechanisms and metabolic implications of regional
differences among fat depots.” Cell Metabolism 17
(5): 644–56. https://doi.org/10.1016/j.cmet.2013.03.008.
Van Harmelen, V., S. Reynisdottir, P. Eriksson, et al. 1998.
“Leptin secretion from subcutaneous and
visceral adipose tissue in women.” Diabetes 47
(6): 913–17. https://doi.org/10.2337/diabetes.47.6.913.
Virtue, S., and A. Vidal-Puig. 2010. “Adipose
tissue expandability, lipotoxicity and the Metabolic Syndrome–an
allostatic perspective.” Biochimica Et Biophysica
Acta 1801 (3): 338–49. https://doi.org/10.1016/j.bbalip.2009.12.006.
Wajchenberg, B. L. 2000. “Subcutaneous and
visceral adipose tissue: their relation to the metabolic
syndrome.” Endocrine Reviews 21 (6): 697–738. https://doi.org/10.1210/edrv.21.6.0415.
Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and
Ferrante AW Jr. 2003. “Obesity is associated
with macrophage accumulation in adipose tissue.” The
Journal of Clinical Investigation 112 (12): 1796–808. https://doi.org/10.1172/JCI19246.
Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley.
2000. “Enlarged subcutaneous abdominal
adipocyte size, but not obesity itself, predicts type II diabetes
independent of insulin resistance.” Diabetologia
43 (12): 1498–506. https://doi.org/10.1007/s001250051560.
WHO Expert Consultation. 2004. “Appropriate
body-mass index for Asian populations and its implications for policy
and intervention strategies.” Lancet (London,
England) 363 (9403): 157–63. https://doi.org/10.1016/S0140-6736(03)15268-3.
Wu, J., P. Boström, L. M. Sparks, et al. 2012. “Beige adipocytes are a distinct type of thermogenic fat
cell in mouse and human.” Cell 150 (2): 366–76.
https://doi.org/10.1016/j.cell.2012.05.016.
Yamauchi, T., J. Kamon, H. Waki, et al. 2001. “The fat-derived hormone adiponectin reverses insulin
resistance associated with both lipoatrophy and obesity.”
Nature Medicine 7 (8): 941–46. https://doi.org/10.1038/90984.
菅波孝祥. 2024.
“加齢による皮下脂肪萎縮の分子基盤の解明.”
コスメトロジー研究報告(コーセーコスメトロジー研究財団)
32: 109–13. https://www.kose-cosmetology.or.jp/research_report/archives/2024/fullVersion/Cosmetology_Vol32_2024_p109-113_Takayoshi_Suganuma.pdf.
日本語で読める関連資料(本文では引用していないもの)
以下は内容の入門・補足として読める日本語の資料です。本資料の作成時に本文を確認できなかったため、本文の主張の出典としては使っていません。
- 前田法一, 下村伊一郎. 肥満症とアディポサイトカイン. 日本内科学会雑誌. 2011;100(4):911–. https://www.jstage.jst.go.jp/article/naika/100/4/100_911/_pdf
- 菅波孝祥, 小川佳宏. 肥満症と炎症. 日本内科学会雑誌. 2011;100(4):989–. https://www.jstage.jst.go.jp/article/naika/100/4/100_989/_pdf
- 石川耕, 横手幸太郎. 脂肪組織機能異常とインスリン抵抗性. 日本内科学会雑誌. 2013;102(10):2691–. https://www.jstage.jst.go.jp/article/naika/102/10/102_2691/_pdf
- 国立健康・栄養研究所「健康食品」の安全性・有効性情報. 【第17回】体脂肪、内臓脂肪、皮下脂肪とは. https://hfnet.nibn.go.jp/column/%E3%80%90%E7%AC%AC17%E5%9B%9E%E3%80%91%E4%BD%93%E8%84%82%E8%82%AA%E3%80%81%E5%86%85%E8%87%93%E8%84%82%E8%82%AA%E3%80%81%E7%9A%AE%E4%B8%8B%E8%84%82%E8%82%AA%E3%81%A8%E3%81%AF/